ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/03/31 | 2,281 | 2,292 | 2,249 | 2,257 | -59 | -2.5% | 106,500 |
2025/03/28 | 2,341 | 2,341 | 2,310 | 2,316 | -30 | -1.3% | 118,000 |
2025/03/27 | 2,295 | 2,374 | 2,288 | 2,346 | +28 | +1.2% | 212,300 |
2025/03/26 | 2,319 | 2,342 | 2,306 | 2,318 | +12 | +0.5% | 121,500 |
2025/03/25 | 2,317 | 2,317 | 2,263 | 2,306 | +6 | +0.3% | 64,100 |
2025/03/24 | 2,313 | 2,319 | 2,277 | 2,300 | +15 | +0.7% | 122,100 |
2025/03/21 | 2,271 | 2,298 | 2,271 | 2,285 | +17 | +0.7% | 89,300 |
2025/03/19 | 2,252 | 2,289 | 2,252 | 2,268 | +15 | +0.7% | 47,200 |
2025/03/18 | 2,258 | 2,272 | 2,245 | 2,253 | -4 | -0.2% | 45,100 |
2025/03/17 | 2,236 | 2,261 | 2,235 | 2,257 | +22 | +1% | 52,400 |
2025/03/14 | 2,256 | 2,265 | 2,235 | 2,235 | -25 | -1.1% | 63,400 |
2025/03/13 | 2,241 | 2,267 | 2,234 | 2,260 | +13 | +0.6% | 76,300 |
2025/03/12 | 2,208 | 2,257 | 2,193 | 2,247 | +55 | +2.5% | 127,300 |
2025/03/11 | 2,195 | 2,208 | 2,167 | 2,192 | +9 | +0.4% | 66,300 |
2025/03/10 | 2,216 | 2,220 | 2,166 | 2,183 | -23 | -1% | 113,500 |
2025/03/07 | 2,219 | 2,226 | 2,186 | 2,206 | -11 | -0.5% | 88,200 |
2025/03/06 | 2,210 | 2,227 | 2,205 | 2,217 | +18 | +0.8% | 81,100 |
2025/03/05 | 2,163 | 2,208 | 2,141 | 2,199 | +55 | +2.6% | 121,700 |
2025/03/04 | 2,147 | 2,156 | 2,111 | 2,144 | +7 | +0.3% | 108,000 |
2025/03/03 | 2,129 | 2,159 | 2,123 | 2,137 | +26 | +1.2% | 129,500 |
2025/02/28 | 2,126 | 2,133 | 2,100 | 2,111 | -8 | -0.4% | 144,100 |
2025/02/27 | 2,067 | 2,125 | 2,063 | 2,119 | +34 | +1.6% | 84,200 |
2025/02/26 | 2,115 | 2,120 | 2,068 | 2,085 | -22 | -1% | 102,700 |
2025/02/25 | 2,007 | 2,115 | 2,004 | 2,107 | +118 | +5.9% | 175,400 |
2025/02/21 | 1,994 | 2,007 | 1,982 | 1,989 | -5 | -0.3% | 80,500 |
2025/02/20 | 2,023 | 2,039 | 1,990 | 1,994 | -34 | -1.7% | 135,300 |
2025/02/19 | 2,030 | 2,042 | 2,022 | 2,028 | -2 | -0.1% | 56,500 |
2025/02/18 | 2,045 | 2,045 | 2,029 | 2,030 | -19 | -0.9% | 60,700 |
2025/02/17 | 2,073 | 2,073 | 2,047 | 2,049 | -18 | -0.9% | 44,000 |
2025/02/14 | 2,100 | 2,100 | 2,057 | 2,067 | -14 | -0.7% | 62,700 |
2025/02/13 | 2,085 | 2,098 | 2,071 | 2,081 | +5 | +0.2% | 51,900 |
2025/02/12 | 2,080 | 2,085 | 2,057 | 2,076 | +2 | +0.1% | 69,600 |
2025/02/10 | 2,100 | 2,102 | 2,067 | 2,074 | -22 | -1% | 132,700 |
2025/02/07 | 2,094 | 2,113 | 2,050 | 2,096 | -46 | -2.1% | 137,800 |
2025/02/06 | 2,219 | 2,223 | 2,131 | 2,142 | -7 | -0.3% | 190,100 |
2025/02/05 | 2,155 | 2,161 | 2,129 | 2,149 | +3 | +0.1% | 120,400 |
2025/02/04 | 2,186 | 2,193 | 2,140 | 2,146 | -17 | -0.8% | 76,300 |
2025/02/03 | 2,222 | 2,233 | 2,152 | 2,163 | -74 | -3.3% | 90,000 |
2025/01/31 | 2,244 | 2,244 | 2,208 | 2,237 | -3 | -0.1% | 41,000 |
2025/01/30 | 2,220 | 2,240 | 2,214 | 2,240 | +12 | +0.5% | 63,100 |
2025/01/29 | 2,267 | 2,267 | 2,222 | 2,228 | -24 | -1.1% | 37,800 |
2025/01/28 | 2,270 | 2,272 | 2,252 | 2,252 | -2 | -0.1% | 31,700 |
2025/01/27 | 2,272 | 2,272 | 2,243 | 2,254 | +5 | +0.2% | 26,100 |
2025/01/24 | 2,243 | 2,274 | 2,236 | 2,249 | +18 | +0.8% | 64,300 |
2025/01/23 | 2,246 | 2,246 | 2,208 | 2,231 | +8 | +0.4% | 77,400 |
2025/01/22 | 2,270 | 2,270 | 2,219 | 2,223 | -39 | -1.7% | 51,300 |
2025/01/21 | 2,229 | 2,262 | 2,226 | 2,262 | +43 | +1.9% | 61,500 |
2025/01/20 | 2,211 | 2,227 | 2,195 | 2,219 | +8 | +0.4% | 37,500 |
2025/01/17 | 2,202 | 2,219 | 2,172 | 2,211 | +13 | +0.6% | 67,000 |
2025/01/16 | 2,210 | 2,210 | 2,184 | 2,198 | -9 | -0.4% | 66,000 |
101~
150
件表示中 / 3769件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 206,000円 | +3.1% | -6.5% | 2.33% | 9.56倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 274,000円 | +21.7% | +999.9% | 0.00% | 12.62倍 | 4.32倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 318,500円 | +5.1% | -7.0% | 2.51% | 20.91倍 | 0.86倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 154,600円 | -2.4% | -52.3% | 3.69% | 18.50倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 238,900円 | +4.1% | -3.1% | 2.43% | 20.75倍 | 1.81倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム